PodcastsEducationHematologic Oncology Update

Hematologic Oncology Update

Dr. Neil Love
Hematologic Oncology Update
Latest episode

129 episodes

  • Hematologic Oncology Update

    Multiple Myeloma: Inside the Issue of Cereblon E3 Ligase Modulators

    18/2/2026 | 57 mins.
    Dr Natalie S Callander from the University of Wisconsin Carbone Cancer Center in Madison and Dr Paul G Richardson from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss the potential role of CELMoDs in the management of multiple myeloma, supporting clinical data and ongoing investigations.
    CME information and select publications here.
  • Hematologic Oncology Update

    Relapsed/Refractory Multiple Myeloma — Microlearning Activity 2 with Dr Sagar Lonial: ASH 2025 Review

    13/2/2026 | 17 mins.
    Dr Sagar Lonial from Winship Cancer Institute in Atlanta, Georgia, discusses recent clinical developments with BCMA-targeted therapy and investigational agents for relapsed/refractory multiple myeloma presented at ASH 2025.
    CME information and select publications here.
  • Hematologic Oncology Update

    Immune Thrombocytopenia — ASH 2025 Review

    06/2/2026 | 1h 30 mins.
    Dr Hanny Al-Samkari from Massachusetts General Hospital in Boston, Dr Cindy Neunert from Columbia University Irving Medical Center in New York and Prof Francesco Zaja from ASUGI in Trieste, Italy discuss cases of immune thrombocytopenia and recent findings from the 2025 ASH Annual Meeting.
    CME information and select publications here.
  • Hematologic Oncology Update

    Relapsed/Refractory Multiple Myeloma — Microlearning Activity 1 with Dr Sagar Lonial: ASH 2025 Review

    03/2/2026 | 23 mins.
    Dr Sagar Lonial from Winship Cancer Institute in Atlanta, Georgia, discusses recent clinical developments with BCMA-targeted therapy and investigational agents for relapsed/refractory multiple myeloma presented at ASH 2025.
    CME information and select publications here.
  • Hematologic Oncology Update

    Bispecific Antibodies in the Management of Lymphoma — ASH 2025 Review

    21/1/2026 | 1h 1 mins.
    Prof Michael Dickinson from Peter MacCallum Cancer Centre in Melbourne, Australia, and Dr Laurie H Sehn from the University of British Columbia in Vancouver, Canada, discuss clinical cases and recent findings from the 2025 ASH Annual Meeting relating to the use of bispecific antibodies in the management of lymphoma.
    CME information and select publications here.

More Education podcasts

About Hematologic Oncology Update

Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
Podcast website

Listen to Hematologic Oncology Update, Keep The Change and many other podcasts from around the world with the radio.net app

Get the free radio.net app

  • Stations and podcasts to bookmark
  • Stream via Wi-Fi or Bluetooth
  • Supports Carplay & Android Auto
  • Many other app features

Hematologic Oncology Update: Podcasts in Family

  • Podcast Oncology Today with Dr Neil Love
    Oncology Today with Dr Neil Love
    Science, Health & Wellness, Medicine, Education
Social
v8.6.0 | © 2007-2026 radio.de GmbH
Generated: 2/23/2026 - 1:25:11 AM